Czech Republic's Zentiva Snaps Up Alvogen’s CEE Operations
Executive SummaryAcquiring Alvogen’s operations in central and eastern Europe will strengthen private equity-backed Zentiva’s presence in both the OTC and generics markets.
You may also be interested in...
Through an initial public offering, Egyptian branded generics supplier Rameda intends to raise funds to buy both products and companies in the Middle East and North Africa.
US niche generics player Teligent intends to use its expertise in topical and injectable drugs manufacturing to push into the North American ophthalmics sector.